PREVALENCE OF DEPRESSION AND ANXIETY AMONG COPD PATIENTS AND ASSOCIATION WITH CAT SCORE

S AYUB; T EJAZ; A EJAZ; JA KHAN; S TAREEN

doi:10.54112/bcsrj.v2024i1.963

Authors

S AYUB Fatima Jinnah Chest Hospital, Quetta, Pakistan
T EJAZ Aga Khan University Hospital, Karachi, Pakistan
A EJAZ Fatima Jinnah Chest Hospital, Quetta, Pakistan
JA KHAN Aga Khan University Hospital, Karachi, Pakistan
S TAREEN Aga Khan University Hospital, Karachi, Pakistan

DOI:

https://doi.org/10.54112/bcsrj.v2024i1.963

Keywords:

Anxiety, Chronic Obstructive Pulmonary Disease, Depression, Prevalence, Risk Factors

Abstract

Chronic obstructive pulmonary disease (COPD) is a global health problem associated with considerable mortality and morbidity. Objective: This study aimed to determine the prevalence of anxiety and depression among COPD patients living in and to evaluate the associated factors. Furthermore, the utility of the CAT score in predicting depression was also assessed. Methodology: This Prospective observational study was conducted at Aga Khan University Hospital Karachi and Aria Institute of Medical Sciences, Quetta, after approval from the ethical review committee for sample size calculation WHO calculator, based on the prior prevalence of COPD in 10.6% of Pakistani general population. Data were collected from 125 patients through a non-probability consecutive sampling technique. Results: Data were collected from 125 patients according to inclusion and exclusion criteria with a male predominance (96 males, 76.8%) compared to females (29 females, 23.2%). The majority of the participants were ex-smokers (104, 83.2%), followed by those who never smoked (13, 10.4%) and current smokers (8, 6.4%). The mean age of the participants was 64.1 years (±7.01), with an age range from 40 to 95 years. The descriptive statistics for anxiety scores among the 125 COPD patients indicate a mean score of 1.35 with a standard deviation of 0.46. Conclusion: It is concluded that a significant proportion of COPD patients experience high levels of anxiety (70.4%) and depression (67.2%). The chi-square test revealed no significant association between these conditions, indicating they occur independently.

Downloads

Download data is not yet available.

References

Quaderi SA, Hurst JR. The unmet global burden of COPD. Glob Heal Epidemiol Genomics. 2018;3:9–11.

Eisner MD, Blanc PD, Yelin EH, Katz PP, Sanchez G, Iribarren C, et al. Influence of anxiety on health outcomes in COPD. Thorax. 2010;65(3):229–34.

Willgoss TG, Yohannes AM. Anxiety Disorders in Patients With Chronic Obstructive Pulmonary Disease: A Systematic Review. Respir Care. 2012;58(5):858–66.

Motiani B, Haidri FR, Rizvi N. Frequency of depression in chronic obstructive pulmonary disease (COPD) patients. Pakistan J Med Sci. 2011;27(5):1112–5.

Himani G, Badini A, Nanji K. Depression and its Associated Factors among Patients with Chronic Obstructive Pulmonary Disease in Karachi, Pakistan. Cureus. 2018;10(7).

Atlantis E, Fahey P, Cochrane B, Smith S. Bidirectional associations between clinically relevant depression or anxiety and COPD: A systematic review and meta-analysis. Chest. 2013;144(3):766–77.

Tetikkurt C, Ozdemir I, Tetikkurt S, Yılmaz N, Ertan T, Bayar N. Anxiety and depression in COPD patients and correlation with sputum and BAL cytology Ansietà e depressione nei pazienti con BPCO e correlazione con la citologia dell’espettorato e del BAL. Multidiscip Respir Med. 2011;6(4):226–31.

Yohannes AM, Mülerová H, Lavoie K, Vestbo J, Rennard SI, Wouters E, et al. The Association of Depressive Symptoms With Rates of Acute Exacerbations in Patients With COPD: Results From a 3-year Longitudinal Follow-up of the ECLIPSE Cohort. J Am Med Dir Assoc. 2017;18(11):955-959.e6.

Paine NJ, Bacon SL, Bourbeau J, Tan WC, Lavoie KL, Aaron SD, et al. Psychological distress is related to poor health behaviours in COPD and non-COPD patients: Evidence from the CanCOLD study. Respir Med. 2019;146(August 2018):1–9.

Yohannes AM, Alexopoulos GS. Depression and anxiety in patients with COPD. Eur Respir Rev. 2014;23(133):345–9.

Agarwal A, Batra S, Prasad R, Verma A, Jilani AQ, Kant S. A study on the prevalence of depression and the severity of depression in chronic obstructive pulmonary disease patients in a semi-urban Indian population. Monaldi Arch Chest Dis. 2018;88(1).

Negi H, Sarkar M, Raval AD, Pandey K, Das P. Presence of depression & its risk factors in chronic obstructive pulmonary disease patients. Indian J Med Res. 2014;139(MAR):402–8.

Lou P, Zhu Y, Zhao J. Prevalence and correlations with depression, anxiety, and other features in outpatients with chronic obstructive pulmonary disease in China : a cross-sectional case-control study Background Trial registration Methods Sampling strategy. 2015;1–9.

Xiao T, Qiu H, Chen Y, Zhou X, Wu K, Ruan X, et al. Prevalence of anxiety and depression symptoms and their associated factors in mild COPD patients from community settings, Shanghai, China: A cross-sectional study. BMC Psychiatry. 2018;18(1):1–7.

Husain MO, Chaudhry IB, Blakemore A, Shakoor S, Husain MA, Lane S, Kiran T, Jafri F, Memon R, Panagioti M, Husain N. Prevalence of depression and anxiety in patients with chronic obstructive pulmonary disease and their association with psychosocial outcomes: A cross-sectional study from Pakistan. SAGE Open Med. 2021 Oct 7;9:20503121211032813. Doi: 10.1177/20503121211032813. PMID: 34659761; PMCID: PMC8511919.

Nicolini A, Barbagelata E, Tagliabue E, et al. Gender differences in chronic obstructive pulmonary diseases: a narrative review. Panminerva Med 2018; 60(4): 192–199.

Raghavan D, Varkey A, Bartter T. Chronic obstructive pulmonary disease: the impact of gender. Curr Opin Pulm Med 2017; 23(2): 117–123.

Xu K., Li X. Risk Factors for Depression in Patients with Chronic Obstructive Pulmonary Disease. Med. Sci. Monit. 2018;24:1417–1423. doi: 10.12659/MSM.904969.

Pumar M.I., Gray C.R., Walsh J.R., Yang I.A., Rolls T.A., Ward D.L. Anxiety and depression-Important psychological comorbidities of COPD. J. Thorac. Dis. 2014;6:1615–1631. doi: 10.3978/j.issn.2072-1439.2014.09.28.

Rahi MS, Thilagar B, Balaji S, Prabhakaran SY, Mudgal M, Rajoo S, Yella PR, Satija P, Zagorulko A, Gunasekaran K. The Impact of Anxiety and Depression in Chronic Obstructive Pulmonary Disease. Adv Respir Med. 2023 Mar 10;91(2):123-134. doi: 10.3390/arm91020011. PMID: 36960961; PMCID: PMC10037643.

Adeloye D., Song P., Zhu Y., Campbell H., Sheikh A., Rudan I. Global, regional, and national prevalence of, and risk factors for, chronic obstructive pulmonary disease (COPD) in 2019: A systematic review and modelling analysis. Lancet. Respir. Med. 2022;10:447–458. doi: 10.1016/S2213-2600(21)00511-7.

Martucci V.L., Richmond B., Davis L.K., Blackwell T.S., Cox N.J., Samuels D., Velez Edwards D., Aldrich M.C. Fate or coincidence: Do COPD and major depression share genetic risk factors? Hum. Mol. Genet. 2021;30:619–628. doi: 10.1093/hmg/ddab068.

Gunasekaran K., Murthi S., Elango K., Rahi M.S., Thilagar B., Ramalingam S., Voruganti D., Paramasivam V.K., Kolandaivel K.P., Arora A., et al. The Impact of Diabetes Mellitus in Patients with Chronic Obstructive Pulmonary Disease (COPD) Hospitalization. J. Clin. Med. 2021;10:235. doi: 10.3390/jcm10020235